Value-driven project and portfolio management in the pharmaceutical industry: Drug discovery versus drug development – Commonalities and differences in portfolio management practice

Author： Bode-Greuel Kerstin M   Nickisch Klaus J  

Publisher： Palgrave Macmillan Ltd

ISSN： 1478-565X

Source： Journal of Commercial Biotechnology, Vol.14, Iss.4, 2008-10, pp. : 307-325

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Drug discovery of the future: the implications of the human genome project

By Reiss T.  

Trends in Biotechnology, Vol. 19, Iss. 12, 2001-12 ,pp. : 496-499

Elsevier

Access to resources Recommend Favorite

Using photolabile ligands in drug discovery and development

By Dorman G.   Prestwich G.D.  

Trends in Biotechnology, Vol. 18, Iss. 2, 2000-02 ,pp. : 64-77

Elsevier

Access to resources Recommend Favorite

Determining the value of drug development candidates and technology platforms

By Bode-Greuel Kerstin M   Greuel Joachim M  

Journal of Commercial Biotechnology, Vol. 11, Iss. 2, 2005-01 ,pp. : 155-170

Palgrave Macmillan Ltd

Access to resources Recommend Favorite

Neural Networks as Robust Tools in Drug Lead Discovery and Development

By Winkler David A.  

Molecular Biotechnology, Vol. 27, Iss. 2, 2004-06 ,pp. : 139-168

Humana Press, Inc

Access to resources Recommend Favorite

Manipulation of the mouse genome: a multiple impact resource for drug discovery and development

By Prosser H.   Rastan S.  

Trends in Biotechnology, Vol. 21, Iss. 5, 2003-05 ,pp. : 224-232

Elsevier

Access to resources Recommend Favorite